From the University of Ottawa, Departments of Medicine and Innovation in Medical Education; Center for Global Health, University of Ottawa; Division of Rheumatology, Department of Medicine, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute; Centre for Practice-Changing Research, Ottawa Hospital Research Institute; OMERACT, Ottawa; Institute for Work and Health, Toronto, Ontario; Department of Medicine, McGill University, Montreal, Quebec, Canada; University of Liverpool, Department of Biostatistics, COMET, Liverpool, UK; Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA; Sydney Medical School, University of Sydney, Sydney; Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health; Department of Rheumatology, Royal North Shore Hospital, St Leonards, Australia; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health, Amsterdam, the Netherlands.
S. Humphrey-Murto, Associate Professor of Medicine, MD, MEd, University of Ottawa, Departments of Medicine and Innovation in Medical Education; R. Crew, BSc (Hons), University of Liverpool, Department of Biostatistics, COMET; B. Shea, PhD, Center for Global Health, University of Ottawa; S.J. Bartlett, PhD, Professor, Department of Medicine, McGill University, and Adjunct Professor, Department of Medicine, Johns Hopkins University; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Sydney Medical School, University of Sydney, and Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health, and Department of Rheumatology, Royal North Shore Hospital; P. Tugwell, MD, Division of Rheumatology, Department of Medicine, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; L.J. Maxwell, PhD, Centre for Practice-Changing Research, Ottawa Hospital Research Institute, and University of Ottawa; D. Beaton, BscOT, PhD, Senior Scientist, Institute for Work and Health; S. Grosskleg, OMERACT, and University of Ottawa; M. de Wit, PhD, Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health.
J Rheumatol. 2019 Aug;46(8):1041-1046. doi: 10.3899/jrheum.181094. Epub 2019 Feb 15.
Developing international consensus on outcome measures for clinical trials is challenging. The following paper will review consensus building in Outcome Measures in Rheumatology (OMERACT), with a focus on the Delphi.
Based on the literature and feedback from delegates at OMERACT 2018, a set of recommendations is provided in the form of the OMERACT Delphi Consensus Checklist.
The OMERACT delegates generally supported the use of the checklist as a guide. The checklist provides guidance for clearly outlining the multiple aspects of the Delphi process.
OMERACT is deeply committed to consensus building and these recommendations should be considered a work in progress.
制定临床试验结果衡量标准的国际共识极具挑战性。本文将回顾风湿病疗效评估方法学组织(OMERACT)中的共识建立过程,重点介绍德尔菲法。
根据文献和 2018 年 OMERACT 会议代表的反馈,以 OMERACT 德尔菲共识清单的形式提供了一系列建议。
OMERACT 代表普遍支持使用该清单作为指南。该清单为明确列出德尔菲法的多个方面提供了指导。
OMERACT 致力于建立共识,这些建议应被视为一个不断发展的过程。